| Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation JK Chung, YJ Park, TY Kim, Y So, SK Kim, DJ Park, DS Lee, MC Lee, ... Clinical endocrinology 57 (2), 215-221, 2002 | 222 | 2002 |
| Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer DY Kim, JH Kim, SH Lee, TY Kim, DS Heo, YJ Bang, NK Kim Annals of oncology 14 (3), 383-387, 2003 | 221 | 2003 |
| Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer SW Han, DY Oh, SA Im, SR Park, KW Lee, HS Song, NS Lee, KH Lee, ... British journal of cancer 100 (2), 298-304, 2009 | 201 | 2009 |
| Genomic signatures of specialized metabolism in plants L Chae, T Kim, R Nilo-Poyanco, SY Rhee science 344 (6183), 510-513, 2014 | 187 | 2014 |
| In the Park HV Lee St. Martin's Press, 1998 | 179* | 1998 |
| Study of W boson production in pPb collisions at sqrt (s [NN])= 5.02 TeV CMS collaboration arXiv preprint arXiv:1503.05825, 2015 | 162* | 2015 |
| Genome-wide prediction of metabolic enzymes, pathways, and gene clusters in plants P Schläpfer, P Zhang, C Wang, T Kim, M Banf, L Chae, K Dreher, ... Plant physiology 173 (4), 2041-2059, 2017 | 153 | 2017 |
| Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia JH Lee, J Kim, K Kim, YH Jo, JE Rhee, TY Kim, SH Na, SS Hwang Journal of critical care 26 (3), 287-294, 2011 | 143 | 2011 |
| Interfacial bond strength of glass fiber reinforced polymer bars in high-strength concrete JY Lee, TY Kim, TJ Kim, CK Yi, JS Park, YC You, YH Park Composites Part B: Engineering 39 (2), 258-270, 2008 | 139 | 2008 |
| Usefulness of artificial neural networks for early warning system of economic crisis TY Kim, KJ Oh, I Sohn, C Hwang Expert Systems with Applications 26 (4), 583-590, 2004 | 138 | 2004 |
| Light controllable surface coating for effective photothermal killing of bacteria SH Kim, EB Kang, CJ Jeong, SM Sharker, I In, SY Park ACS applied materials & interfaces 7 (28), 15600-15606, 2015 | 134 | 2015 |
| IMbrave150: efficacy and safety results from a ph III study evaluating atezolizumab (atezo)+ bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts … AL Cheng, S Qin, M Ikeda, P Galle, M Ducreux, A Zhu, TY Kim, M Kudo, ... Annals of Oncology 30, ix186-ix187, 2019 | 132 | 2019 |
| Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis HS Kim, HJ Kim, SY Kim, TY Kim, KW Lee, SK Baek, MH Ryu, BH Nam, ... Annals of Oncology 24 (11), 2850-2854, 2013 | 131 | 2013 |
| Nonsurgical placement of a nasolacrimal polyurethane stent. HY Song, YH Jin, JH Kim, SJ Huh, YH Kim, TH Kim, KB Sung Radiology 194 (1), 233-237, 1995 | 121 | 1995 |
| Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised … C Eng, TW Kim, J Bendell, G Argilés, NC Tebbutt, M Di Bartolomeo, ... The Lancet Oncology 20 (6), 849-861, 2019 | 120 | 2019 |
| Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility TY Kim, D Vigil, CJ Der, RL Juliano Cancer and Metastasis Reviews 28 (1), 77-83, 2009 | 119 | 2009 |
| Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location JM Bae, JH Kim, NY Cho, TY Kim, GH Kang British journal of cancer 109 (4), 1004-1012, 2013 | 113 | 2013 |
| High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small … DW Kim, HS Min, KH Lee, YJ Kim, DY Oh, YK Jeon, SH Lee, SA Im, ... British journal of cancer 98 (6), 1118-1124, 2008 | 112 | 2008 |
| Choi HS Kim, T Kim Lee, JE, 1095-1101, 2010 | 111 | 2010 |
| pH triggered in vivo photothermal therapy and fluorescence nanoplatform of cancer based on responsive polymer-indocyanine green integrated reduced graphene oxide SM Sharker, JE Lee, SH Kim, JH Jeong, I In, H Lee, SY Park Biomaterials 61, 229-238, 2015 | 109 | 2015 |
